Hepatitis C and methotrexate.
Kujawska
Anna
A
Virginia Commonwealth University and McGuire Veterans Medical Center, Richmond, Virginia, USA. anyya@hotmail.com
Clements
MaryPat
M
Wise
Christopher M
CM
Roberts
W Neal
WN
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D015331:Cohort Studies; D005260:Female; D019983:Guideline Adherence; D006526:Hepatitis C / Q000139:chemically induced* / Q000150:complications / Q000276:immunology; D006785:Hospitals, University; D006787:Hospitals, Veterans; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D012189:Retrospective Studies
D007166:Immunosuppressive Agents; D008727:Methotrexate